Top Markets
#1 Asteroid Shiba Asteroid Shiba +111,233.42%
#2 Moonriver Moonriver +185.52%
#3 inSure DeFi inSure DeFi +124.89%
#4 Lorenzo stBTC Lorenzo stBTC +78.86%
#5 Metis Metis +45.51%
#6 SOON SOON +41.81%
#7 tomiNet tomiNet +41.49%
#8 Sapien Sapien +35.31%
#9 Audius Audius +33.12%
#10 ZetaChain ZetaChain +21.23%
Coin of the day
Asteroid Shiba Asteroid Shiba
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Malin Corporation plc Malin Corporation plc

Malin Corporation plc

MLC
Classifica tra le azioni #20971
Malin Corporation plc, through its subsidiaries, operates in the life sciences... Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.
Prezzo delle azioni
$9.13
Capitalizzazione di mercato
$39.27K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-11.76%
Paese
IE
Scambia Malin Corporation plc (MLC)

Categoria

Healthcare
Ricavi di Malin Corporation plc (MLC)
Ricavi nel Dec 2025 TTM: 0.00
Secondo gli ultimi rapporti finanziari di Malin Corporation plc, i ricavi attuali dell'azienda (TTM) sono pari a 0.00. Nel 2023, l'azienda ha registrato ricavi di 0.00 uguale a i ricavi dell'anno 2022, che erano pari a 0.00. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Malin Corporation plc da 2015 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) 0.00 0.00%
2024 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 -100.00%
2020 $49.93M 27.52%
2019 $39.16M -10.33%
2018 $43.67M -13.14%
2017 $50.28M 13.50%
2016 $44.30M 78.15%
2015 $24.87M 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPSEY.US
 $4.43B -
FR
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MKGAF.US
 $24.76B -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
TAK.US
 $28.60B -
JP
Zoetis Inc. Zoetis Inc.
Zoetis Inc.
ZTS.US
 $9.47B -
US
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.31B -
IN